Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H20ClN3O2 |
InChIKeyILMHDRGZABQLEW-UHFFFAOYSA-N |
CAS Registry2613307-67-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AU | 01 Mar 2021 |